Home > Healthcare > Medical Devices > Therapeutic Devices > Neurostimulation Devices Market

Neurostimulation Devices Market Share

Report ID: GMI436
Published Date: Dec 2023
Report Format: PDF

Download Free Sample

Neurostimulation Devices Market Share

The neurostimulation devices industry is consolidated, with key players including, Abbott Laboratories, Medtronic plc, and others dominating the market space. These companies focus on ongoing product innovation, geographical expansion, and partnerships to secure substantial market share. For instance, in February 2022, Medtronic plc announced that it received approval from the U.S. FDA for InterStim X, the next generation of the InterStim portfolio's recharge-free device which was available immediately in the market. This approval stimulated company’s market position coupled with expanded its customer base.

Some of the eminent market participants operating in the neurostimulation devices industry include:

Abbott Laboratories
Aleva Neurotherapeutics S.A
BioControl Medical
Boston Scientific Corporation
ElectroCore, Inc.
Endostim
Helbling Holding AG
Innovative Health Solutions, Inc.
Laborie, Inc.
LivaNova PLC
Medtronic plc
MicroTransponder
Neuronetics, Inc.
Parasym Ltd.
RS Medical
Synapse Biomedical
tVNS Technologies GmbH (Cerbomed)

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

The market size of neurostimulation devices was worth USD 8.3 billion in 2022 and is projected to reach USD 25.5 billion by 2032, attributed to the surging demand for minimally invasive surgeries coupled with the rising prevalence of neurological disorders.

The spinal cord stimulator segment accounted for USD 3 billion in 2022, due to the rising prevalence of chronic pain and the increasing number of failed back surgeries.

U.S. neurostimulation devices market was worth USD 4 billion in 2022 and is estimated to expand at a robust CAGR from 2023 to 2032, owing to the increasing prevalence of neurological diseases coupled with the increasing R&D activities and adoption of minimally invasive techniques.

Some of the leading neurostimulation devices players are Abbott Laboratories, Aleva Neurotherapeutics S.A, BioControl Medical, Boston Scientific Corporation, Endostim, Innovative Health Solutions, Inc., Laborie, Inc., LivaNova PLC, Medtronic plc, RS Medical, and Synapse Biomedical, among many others.